Pavel Hoffmann (Pavel Hoffman)

Publication Activity (10 Years)

Years Active: 2014-2021
Publications (10 Years): 3

Top Topics

Quality Control

Atrial Fibrillation

St Segment Elevation Myocardial Infarction

Percutaneous Coronary Intervention

Top Venues

Mediators of inflammation

CVIR endovascular

Section for interventional cardiology

University of Göteborg (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Section for interventional cardiology

Norway

MD, PhD :: Department of Cardiology, Oslo University Hospital, Ullevaal

Education History

University of Göteborg

Sweden

PHD

Publications

Jostein Nordeng, Hossein Schandiz, Svein Solheim, Sissel Åkra, Pavel Hoffmann, Borghild Roald, Bjørn Bendz, Harald Arnesen, Ragnhild Helseth, Ingebjørg Seljeflot
The Inflammasome Signaling Pathway Is Actively Regulated and Related to Myocardial Damage in Coronary Thrombi from Patients with STEMI. Mediators of inflammation 2021 (2021)
Ragnhild Helseth, Christian Shetelig, Geir Øystein Andersen, Miriam Sjåstad Langseth, Shanmuganathan Limalanathan, Trine B Opstad, Harald Arnesen, Pavel Hoffmann, Jan Eritsland, Ingebjørg Seljeflot
Neutrophil Extracellular Trap Components Associate with Infarct Size, Ventricular Function, and Clinical Outcome in STEMI. Mediators of inflammation 2019 (2019)
Pavel Hoffmann, Ahmed Al-Ani, Thomas von Lueder, Jenny Hoffmann, Peter Majak, Ove Hagen, Helga Loose, Nils Einar Kløw, Anders Opdahl
Access site complications after transfemoral aortic valve implantation - a comparison of Manta and ProGlide. CVIR endovascular 1 (1) (2018)
Ragnhild Helseth, Svein Solheim, Trine Opstad, Pavel Hoffmann, Harald Arnesen, Ingebjørg Seljeflot
The time profile of Pentraxin 3 in patients with acute ST-elevation myocardial infarction and stable angina pectoris undergoing percutaneous coronary intervention. Mediators of inflammation 2014 (2014)